SCYL1 variants cause a syndrome with lowγ-glutamyl-transferase cholestasis, acute liver failure, and neurodegeneration (CALFAN)
Author(s) -
Dominic Lenz,
Patricia McClean,
Aydan Kansu,
Penelope E. Bonnen,
Giusy Ranucci,
Christian Thiel,
Beate K. Straub,
Inga Harting,
Bader Alhaddad,
Bianca Dimitrov,
Urania Kotzaeridou,
Daniel Wenning,
Raffaele Iorio,
Ryan Himes,
Zarife Kuloğlu,
Emma L. Blakely,
Robert W. Taylor,
Thomas Meitinger,
Stefan Kölker,
Holger Prokisch,
Georg F. Hoffmann,
Tobias B. Haack,
Christian Staufner
Publication year - 2018
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1038/gim.2017.260
Subject(s) - cholestasis , medicine , progressive familial intrahepatic cholestasis , phenotype , gastroenterology , pathology , biology , liver transplantation , genetics , gene , transplantation
Biallelic mutations in SCYL1 were recently identified as causing a syndromal disorder characterized by peripheral neuropathy, cerebellar atrophy, ataxia, and recurrent episodes of liver failure. The occurrence of SCYL1 deficiency among patients with previously undetermined infantile cholestasis or acute liver failure has not been studied; furthermore, little is known regarding the hepatic phenotype.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom